Filter By Category
Archives
Share on -
ARUNDIC ACID
Generic Name: ARUNDIC ACID
ABSTRACT -
Arundic acid, also known as ONO-2506, is an investigational neuroprotective agent described as an astrocyte-modulating compound. It has been studied in acute ischemic stroke and explored in neurodegenerative disorders such as amyotrophic lateral sclerosis and Parkinsonian conditions. It is not a routine approved neuroprotective therapy.
DOSAGE -
- No approved routine dosage regimen is established.
- Clinical-study dosing has used protocol-defined IV or oral formulations depending on indication and development stage.
- Dose selection must account for time from stroke onset or disease stage, neurologic status, hepatic/renal function, and trial eligibility.
- Do not use in place of approved stroke emergency treatments.
SIDE EFFECTS–
- Headache, dizziness, nausea, vomiting, abdominal discomfort, or fatigue
- Infusion-site reactions with IV use
- Laboratory changes in liver enzymes, renal markers, or hematology
- Neurologic symptoms may reflect the underlying disease rather than drug effect
- Rash or hypersensitivity reactions
ALLERGIC REACTIONS -
- Hypersensitivity may include rash, hives, swelling, wheezing, hypotension, or anaphylaxis.
- Severe reactions require discontinuation and urgent care.
DRUG INTERACTIONS-
- Other investigational neuroprotective agents, anticoagulants, antiplatelets, thrombolytics, sedatives, and hepatotoxic drugs require protocol review.
- Potential interactions with valproate-like compounds or CNS-active medicines should be considered by class analogy.
- Avoid unapproved combinations.
PREAUTIONS–
- Acute stroke requires emergency guideline-directed evaluation, reperfusion decisions, and supportive care.
- Monitor neurologic status, liver/renal function, bleeding risk, and concomitant antithrombotic therapy.
- Use caution in pregnancy, breastfeeding, hepatic disease, and severe systemic illness.
- Research use should include informed consent and appropriate monitoring.
WARNINGS –
- Investigational status means efficacy and routine benefit-risk are not established.
- Do not delay emergency stroke treatment to obtain arundic acid.
- New neurologic deterioration, severe allergy, or organ dysfunction requires urgent care.
- Keep out of reach of children.
Share on -
. Developed by